Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Cardiac resynchronization therapy" patented technology

Cardiac resynchronisation therapy (CRT or CRT-P) is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles via a pacemaker, a small device inserted into the interior chest wall.

Implantable Medical Device for Cardiac Resynchronization Therapy Featuring an Automatic Adaptation of a Stimulation Parameter

PendingUS20260199687A1Ventricular contractionBiology
Implantable medical device for stimulating a heart includes a proximal electrode pole, and first and second distal electrode poles. During operation, the device performs: a) detecting an intrinsic atrial contraction of the heart; b) detecting an intrinsic ventricular contraction of the heart; c) determining a first intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and ii) the intrinsic ventricular contraction detected with the first distal electrode pole; and determining a second intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and iii) the intrinsic ventricular contraction detected with the second distal electrode pole; d) setting a stimulated atrioventricular conduction time for stimulating the ventricle of the heart with the first and / or second distal electrode poles, the stimulated atrioventricular conduction time being shorter than the shorter of the first and second intrinsic atrioventricular conduction times.
Owner:BIOTRONIK SE & CO KG

Modulate pacing rate to increase the percentage of effective ventricular capture during atrial fibrillation

The present disclosure pertains to cardiac pacing methods and systems, and, more particularly, to cardiac resynchronization therapy (CRT). In particular, the present disclosure pertains to determining whether a patient is experiencing atrial fibrillation (AF). If the patient is experiencing AF, the efficacy of CRT is determined. A signal is sensed in response to a ventricular pacing stimulus. Through signal processing, a number of features are parsed from the signal and a determination is made as to whether the ventricular pacing stimulus evoked a response from the ventricle.
Owner:MEDTRONIC INC

Implantable medical device for cardiac resynchronization therapy featuring automatic adaptation of stimulation parameters

PendingCN122161646AHeart stimulatorsVentricular contractionAv conduction
The invention relates to an implantable medical device for stimulating a human or animal heart, the device comprising a single electrode (20) comprising a proximal electrode pole (213) designed and arranged to be implanted within an atrium (2) of the heart (1) to be stimulated and a distal electrode pole (203) designed and arranged to be implanted within a septum (13) of the heart (1) to be stimulated. During operation, the implantable medical device performs the following steps: a) detecting (500) an intrinsic atrial contraction of the heart (1) to be stimulated with the proximal electrode pole (213) or stimulating (500) the atrium (2) of the heart (1) to be stimulated with the proximal electrode pole (213); b) detecting (530) an intrinsic ventricular contraction of the heart (1) to be stimulated with the distal electrode pole (203); c) determining (530) an intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and ii) the intrinsic ventricular contraction; d) setting (550) a stimulated atrioventricular conduction time for stimulating a ventricle (3, 5) of the heart (1) to be stimulated with the distal electrode pole (203), the stimulated atrioventricular conduction time being shorter than the intrinsic atrioventricular conduction time.
Owner:BIOTRONIK SE & CO KG